These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2345923

  • 1. Neurocysticercosis: treatment with albendazole.
    Horton J.
    Trans R Soc Trop Med Hyg; 1990; 84(1):174. PubMed ID: 2345923
    [No Abstract] [Full Text] [Related]

  • 2. Albendazole in neurocysticercosis.
    Kapil D, Vohra P.
    Indian J Pediatr; 1993; 60(1):131-2. PubMed ID: 8244473
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Albendazole therapy for neurocysticercosis.
    Takayanagui OM.
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521303
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Albendazole--newer therapy for neurocysticercosis.
    Dharnidharka VR.
    J R Soc Health; 1993 Feb; 113(1):51. PubMed ID: 8437170
    [No Abstract] [Full Text] [Related]

  • 7. Albendazole treatment of neurocysticercosis.
    Chotmongkol V.
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):344-7. PubMed ID: 1439991
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neurocysticercosis: optimal dose treatment with albendazole.
    Cruz I, Cruz ME, Carrasco F, Horton J.
    J Neurol Sci; 1995 Nov; 133(1-2):152-4. PubMed ID: 8583218
    [Abstract] [Full Text] [Related]

  • 10. Albendazole therapy in ring lesions of neurocysticercosis.
    Lowalekar KB.
    J Assoc Physicians India; 1992 Oct; 40(10):694-6. PubMed ID: 1307363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
    Chagnon A, Galzin M, de Jaureguiberry JP, Boyer B, Paris JF, Marlier S, Carli P.
    Med Trop (Mars); 1994 Oct; 54(3):275-6. PubMed ID: 7885211
    [No Abstract] [Full Text] [Related]

  • 15. Albendazole in neurocysticercosis.
    Padma MV, Behari M, Misra NK, Ahuja GK.
    Natl Med J India; 1995 Oct; 8(6):255-8. PubMed ID: 8520442
    [Abstract] [Full Text] [Related]

  • 16. Is medical treatment of neurocysticercosis effective?
    Garg RK.
    Natl Med J India; 1995 Oct; 8(6):269-70. PubMed ID: 8520446
    [No Abstract] [Full Text] [Related]

  • 17. Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report.
    del Brutto OH, Sotelo J.
    J Neurosurg; 1990 May; 72(5):816-7. PubMed ID: 2324806
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H, Hurtado M, Sanchez M, Medina MT, Sotelo J.
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [Abstract] [Full Text] [Related]

  • 20. Neurocysticercosis treated with albendazole long term follow-up of a case.
    Maddalena G, Nozzoli C, Passarella B.
    J Neurosurg Sci; 1995 Sep; 39(3):171-5. PubMed ID: 8965125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.